Highly Potent Parenterals | |
|
|
The economics of outsourcing highly potent molecules has always required careful decisionmaking, but even more so with today’s pipeline that includes less “blockbuster” type drugs and more “niche” or targeted molecules. New approaches to production decisions are needed in order to balance revenue from smaller patient populations with the cost of complex manufacturing processes that must adhere to stringent safety and regulatory requirements. This complimentary webinar from Baxter BioPharma Solutions provides insight on:
Fill form to watch now! |
Food & Beverage: Food & Beverage Development - Europe | Food & Beverage Development - North America | Food Marketing and Retailing | Food Processing & Packaging | Food Safety & Quality Control | Food and Beverage in Asia Pacific | Industrial Baking & Snacks | Beverage Technology & Markets | Confectionery & Biscuit Processing | Dairy Processing & Markets | Prepared Food and Meat Processing Nutrition: Supplements & Nutrition - Europe | Supplements & Nutrition - North America Pharmaceutical: Pharmaceutical Technology | Contract Research, Manufacturing & Clinical Trials Cosmetics: Cosmetics Formulation & Packaging - North America | Cosmetics Formulation & Packaging - Europe
